Position Statement: Ipecac Syrup
- 1 January 1997
- journal article
- case report
- Published by Informa UK Limited in Journal of Toxicology: Clinical Toxicology
- Vol. 35 (7), 699-709
- https://doi.org/10.3109/15563659709162567
Abstract
In preparing this Position Statement, all relevant scientific literature was identified and reviewed critically by acknowledged experts using agreed criteria. Well-conducted clinical and experimental studies were given precedence over anecdotal case reports and abstracts were not usually considered. A draft Position Statement was then produced and subjected to detailed peer review by an international group of clinical toxicologists chosen by the American Academy of Clinical Toxicology and the European Association of Poisons Centres and Clinical Toxicologists. The Position Statement went through multiple drafts before being approved by the boards of the two societies and being endorsed by other societies. The Position Statement includes a summary statement for ease of use and is supported by detailed documentation which describes the scientific evidence on which the Statement is based. Syrup of ipecac should not be administered routinely in the management of poisoned patients. In experimental studies the amount of marker removed by ipecac was highly variable and diminished with time. There is no evidence from clinical studies that ipecac improves the outcome of poisoned patients and its routine administration in the emergency department should be abandoned. There are insufficient data to support or exclude ipecac administration soon after poison ingestion. Ipecac may delay the administration or reduce the effectiveness of activated charcoal, oral antidotes, and whole bowel irrigation. Ipecac should not be administered to a patient who has a decreased level or impending loss of consciousness or who has ingested a corrosive substance or hydrocarbon with high aspiration potential.Keywords
This publication has 31 references indexed in Scilit:
- Home Use of Syrup of Ipecac Is Associated With a Reduction in Pediatric Emergency Department VisitsAnnals of Emergency Medicine, 1995
- Evaluation of gastric emptying using radionuclides: Gastric lavage versus ipecac-induced emesisAnnals of Emergency Medicine, 1993
- Potential misuse of ipecacAnnals of Emergency Medicine, 1993
- Influence of time until emesis on the efficacy of decontamination using acetaminophen as a marker in a pediatric populationAnnals of Emergency Medicine, 1993
- Pediatric ingestions: Charcoal alone versus ipecac and charcoalAnnals of Emergency Medicine, 1991
- Efficacy of charcoal cathartic versus ipecac in reducing serum acetaminophen in a simulated overdoseAnnals of Emergency Medicine, 1989
- Efficacy of ipecac-induced emesis, orogastric lavage, and activated charcoal for acute drug overdoseAnnals of Emergency Medicine, 1987
- Efficacy of gastric emptying: Gastric lavage versus emesis induced with ipecacAnnals of Emergency Medicine, 1986
- Management of acutely poisoned patients without gastric emptyingAnnals of Emergency Medicine, 1985
- Mallory-Weiss syndrome: An unusual complication of ipecac-induced emesisAnnals of Emergency Medicine, 1981